View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Funding Circle Plc: POS-Transaction in Own Shares

Funding Circle Plc (FCH) Funding Circle Plc: POS-Transaction in Own Shares 03-Jun-2024 / 16:59 GMT/BST LEI: 2138003EK6UAINBBUS19   3 June 2024   Funding Circle Holdings plcTransaction in own shares Funding Circle Holdings plc (the "Company") announces that it has purchased for cancellation the following number of its ordinary shares of £0.001 each on the London Stock Exchange from Numis Securities Limited (“Deutsche Numis”) as part of its buy-back announced on 7 March 2024: Date of purchase: 3 June 2024 Number of ordinary shares purchased: 1...

 PRESS RELEASE

ALK launches new growth strategy and 2028 financial ambitions

ALK launches new growth strategy and 2028 financial ambitions ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the Board of Directors has adopted a new corporate strategy (Allergy+) and 2028 financial ambitions. Allergy+ aims to further strengthen ALK’s leadership in allergy immunotherapy, establishing a leading position in food allergy and anaphylaxis, as well as pursuing new innovations to address adjacent allergic conditions with high unmet needs. The strategy targets average revenue growth of minimum 10% in local currencies (5-year CAGR) until 20281. The respiratory SLIT-ta...

Pierre François Merveille
  • Pierre François Merveille

Kantar : IPO candidate ?

Kantar is progressing towards the finalization of its transformation plan. Capex and transformation costs are (at last) expected to decrease significantly and this should pave the way for breakeven FCF in 2024. Operating results are positively oriented thanks to 1/ decent top line growth (+3% expected in 2024) despite the current macro context as well as 2/ margin expansion (better product mix and savings from the efficiency plan). That being said, we expect FCF to remain constra...

Pierre François Merveille
  • Pierre François Merveille

Kantar : IPO candidate?

Kantar is progressing towards the finalization of its transformation plan. Capex and transformation costs are (at last) expected to decrease significantly and this should pave the way for breakeven FCF in 2024. Operating results are positively oriented thanks to 1/ decent top line growth (+3% expected in 2024) despite the current macro context as well as 2/ margin expansion (better product mix and savings from the efficiency plan). That being said, we expect FCF to remain constra...

 PRESS RELEASE

Housing Affordability Is Gen Z’s Top Voting Issue, Outweighing Abortio...

SEATTLE--(BUSINESS WIRE)-- (NASDAQ: RDFN) — More than nine in 10 (91%) adult Gen Zers say housing affordability is important when considering who they will vote for in the upcoming presidential election, making it the top issue for that generation, according to a new from Redfin (), the technology-powered real estate brokerage. Gen Zers were more likely to rate housing affordability as an important factor in their vote than any other issue they were asked about, including the economy, abortion and gun rights, preserving democracy and foreign wars. This is according to a Redfin-commissioned ...

 PRESS RELEASE

FORSEE POWER : Informations relatives au nombre de droits de vote et d...

PARIS--(BUSINESS WIRE)-- Regulatory News: FORSEE POWER (Paris:FORSE): Date Nombre d’actions composant le capital social Nombre de droits de vote BRUT (1) Nombre de droits de vote NET (2) 31/05/2024 71 550 727 88 145 543 87 948 746 Conformément à l’article 223-11 du Règlement général de l’Autorité des marchés financiers, nombre calculé sur la base de l’ensemble des actions auxquelles sont attachées des droits de vote, y compris les actions privées de droit de vote (auto-détention, contrat de liquidité, etc.) Nombre calculé sur la base...

 PRESS RELEASE

Mon courtier énergie groupe : Assemblée générale annuelle mixte du 19 ...

BORDEAUX, France--(BUSINESS WIRE)-- Regulatory News : Mon courtier énergie groupe (code ISIN : FR001400H3A0 - Mnémonique : ALMCE), société de courtage en énergie pour les entreprises, informe ses actionnaires et l’ensemble de la communauté financière que son assemblée générale mixte se tiendra le mercredi 19 juin 2024 à 18h00, au siège social de la Société, 22-26 quai de Bacalan, 33000 Bordeaux. A défaut d’assister personnellement à cette assemblée, les actionnaires peuvent exercer leur droit de vote à distance, avant l’assemblée générale : soit en adressant une procuration à la Société...

 PRESS RELEASE

Medincell : Publication des résultats financiers de l’exercice 2023-20...

MONTPELLIER, France--(BUSINESS WIRE)-- Regulatory News : Medincell (Paris:MEDCL) tiendra une vidéoconférence le lundi 10 juin 2024 à 14h00 pour présenter les résultats annuels de l’exercice clos au 31 mars 2024, qui seront publiés le même jour avant ouverture des marchés. Pour suivre la réunion en français : Pour suivre la réunion en anglais : Le management de la société répondra aux questions des actionnaires qui peuvent être envoyées à , ou pourront être posées en direct pendant la vidéoconférence. A propos de Medincell Medincell est une société de licensing biopharmaceutiqu...

 PRESS RELEASE

VGP NV: Voting Rights and Denominator

VGP NV: Voting Rights and Denominator Press ReleaseRegulated InformationAntwerp, 3 June 2024– 6.00 p.m. CET In application of Article 15 of the Law of May 2, 2007 on the disclosure of major shareholdings in issuers whose shares are admitted for trading on a regulated market, VGP publishes, by means of a press release and on its website, the total share capital, the total number of securities with voting rights and the total number of voting rights at the latest at the end of each month in which any of these numbers has changed. Situation as at 31 May 2024: Total share capital:€ 136,091,...

 PRESS RELEASE

Les Hôtels Baverez : Nombres d'actions et de droits de vote au 31 mai ...

Les Hôtels Baverez : Nombres d'actions et de droits de vote au 31 mai 2024 LES HOTELS BAVEREZ S.A. 2, place des Pyramides 75001 PARISCapital € 10.127.050 – Code NAF 5510 ZR.C.S. PARIS 572 158 558 ISIN : FR 0007080254Mnémonique : ALLHBEURONEXT Growth Nombres d’actions et de droits de vote au 31/05/2024 Au 31 mai 2024, le nombre total d’actions composant le capital social de la société s’élève à 2 372 468. Le nombre total de droits de vote théoriques à la même date est de 3 854 234. Pièces jointes ...

 PRESS RELEASE

CATANA GROUP : RESULTATS SEMESTRIELS 2023/2024   Croissance de l’ens...

CATANA GROUP : RESULTATS SEMESTRIELS 2023/2024   Croissance de l’ensemble des résultats, en ligne avec les objectifs Nette progression du résultat net part du groupe : + 54%   Communiqué de presse         Canet-en-Roussillon, le 3 juin 2024 à 18h RESULTATS SEMESTRIELS 2023/2024 Croissance de l’ensemble des résultats, en ligne avec les objectifsNette progression du résultat net part du groupe : + 54% En millions d'€28.02.2428.02.23Chiffre d’affaires105,794,9Achats consommésCharges de personnelCharges externesImpôts et taxesDotations amortissements et provisionsVariations de stocksAutre...

 PRESS RELEASE

Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumeln...

Crinetics Announces Positive Initial Findings at ENDO 2024 for Atumelnant in Two Ongoing, Open-Label Studies for the Treatment of Congenital Adrenal Hyperplasia (CAH) and ACTH-Dependent Cushing’s Syndrome (ADCS) 100% of Participants (n=6) With CAH Maintained Androstenedione (A4) Below the Upper Limit of Normal at all Time Points on Atumelnant (80 mg) CAH Participants Achieved More Than a 90% Reduction of A4 and 97% Reduction of 17-OHP on Atumelnant (80 mg), Beginning at Two Weeks and Sustained Through 12 Weeks In the ADCS Trial, Atumelnant (80 mg) Normalized 24-hr Urinary Free Cortiso...

 PRESS RELEASE

ADOCIA annonce la nomination de Mathieu‑William Gilbert au poste de Di...

LYON, France--(BUSINESS WIRE)-- Regulatory News: Adocia (Euronext Paris : FR0011184241 – ADOC), société biopharmaceutique au stade clinique spécialisée dans la recherche et le développement de solutions thérapeutiques innovantes pour le traitement du diabète et de l’obésité, annonce aujourd'hui la nomination de Mathieu-William Gilbert au poste de Directeur des Opérations. Mathieu rejoint Adocia après avoir été Vice-Président des Projets Stratégiques au sein des Opérations Commerciales Internationales chez Novo Nordisk. Auparavant, Mathieu a occupé le poste de Vice-Président et Directeur Gé...

 PRESS RELEASE

Laurent-Perrier : Descriptif du programme de rachat d'actions

Laurent-Perrier : Descriptif du programme de rachat d'actions Laurent-PerrierSociété anonyme à Directoire et Conseil de Surveillanceau capital de 22.594.271,80 eurosSiège Social : 32, avenue de Champagne 51150 Tours-sur-Marne335 680 096 RCS Reims Descriptif du programme de rachat d’actionsProposé à l’Assemblée Générale Mixte du 11 juillet 2024 Mise en œuvre du programme de rachat d’actions En application des dispositions des articles 241-1 à 241-6 du Règlement Général de l’Autorité des marchés financiers et du règlement européen n° 596/2014. Emetteur : Laurent-PerrierSociété cotée au c...

 PRESS RELEASE

VGP NV: Stemrechten en Noemer

VGP NV: Stemrechten en Noemer PersberichtGereglementeerde informatieAntwerpen, 3 juni 2024, 18:00 CET In toepassing van artikel 15 van de wet van 2 mei 2007 op de openbaarmaking van belangrijke deelnemingen in emittenten waarvan aandelen zijn toegelaten tot de verhandeling op een gereglementeerde markt, publiceert VGP door middel van een persbericht en op haar website het totaal kapitaal, het totaal aantal stemrechtverlenende effecten en het totale aantal stemrechten uiterlijk op het einde van elke maand waarin één van deze aantallen is gewijzigd. Situatie op 31 mei 2024: Totaal kapitaal:...

 PRESS RELEASE

Crinetics Presents New Data at ENDO 2024 that Increases Body of Eviden...

Crinetics Presents New Data at ENDO 2024 that Increases Body of Evidence Positioning Once-Daily, Oral Paltusotine as Potential First-Choice Treatment Option for Acromegaly First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showing Rapid and Sustained IGF-1 Responses in People Treated with Paltusotine New PATHFNDR-1 Patient-Reported Outcomes Analysis Showed Paltusotine Lessened Day-to-Day Breakthrough Symptom Exacerbations versus Prior Treatment with Standard of Care Injections, as Assessed by Acromegaly Symptom Diary L...

 PRESS RELEASE

Kadant Acquires Dynamic Sealing Technologies

Kadant Acquires Dynamic Sealing Technologies Expands Flow Control Segment with Fluid Rotary Union Manufacturer WESTFORD, Mass., June 03, 2024 (GLOBE NEWSWIRE) -- Kadant Inc. (NYSE: KAI) today announced it has completed the acquisition of Dynamic Sealing Technologies LLC and affiliates (“DSTI”) for approximately $55 million in cash, subject to certain customary adjustments. The acquisition was financed through borrowings under Kadant's revolving credit facility. DSTI is a leader in engineered fluid sealing and transfer solutions for rotating applications. The company specializes in the...

 PRESS RELEASE

Fuller, Smith & Turner PLC: Transaction in own shares

Fuller, Smith & Turner PLC (FSTA) Fuller, Smith & Turner PLC: Transaction in own shares 03-Jun-2024 / 16:51 GMT/BST   Fuller, Smith & Turner P.L.C. (“the Company” or “Fuller’s”)   Transaction in own shares   The Company announces that it has purchased the following number of its ‘A' ordinary shares of 40p each on the London Stock Exchange through Numis Securities Limited as part of its share buyback programme announced on 22 March 2024 (the “Programme”).   Date of Purchase 03/06/2024   Number of ‘A’ ordinary shares of 40p each ...

Airtel Africa Plc 2024FYE Performance - Strong Local Currency Sales Ha...

Currency Woes Persist in Nigeria In three operating regions, AIRTELAFRI recorded stronger YoY reporting currency revenue growth in only Francophone Africa . In reporting currency terms, Francophone Africa grew by 12.39% YoY to NGN1.35bn in 2024FYE (vs. 6.21% YoY in 2023FYE). This growth was stronger than 10.34% YoY in 2024FYE recorded in constant currency (vs. 12.66% YoY in 2023FYE), due to currency appreciation in the Central African Franc during the period.   Stable Operating Margins: Lower...

 PRESS RELEASE

Key Figures 31.05.2024

HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.05.2024 03.06.2024 / 17:46 CET/CEST   in CHF Performance in %   31.05.2024   MTD FYTD CYTD NAV 256.74 0.8 3.5 14.1 Share Price 208.00 11.6 7.4 13.9 Total Net Assets (in million) 1'757       HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Sw...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch